<DOC>
	<DOC>NCT02104921</DOC>
	<brief_summary>This study is utilizing ultrasound measurement to measure neuromuscular disease status in adult patients. The hypothesis is the by quantifying ultrasound data, it is possible that ultrasound can be utilized as a tool to determine if a disease is responding to therapy or progressing.</brief_summary>
	<brief_title>Innovative Ultrasound Technology in Neuromuscular Disease</brief_title>
	<detailed_description />
	<mesh_term>Motor Neuron Disease</mesh_term>
	<mesh_term>Amyotrophic Lateral Sclerosis</mesh_term>
	<mesh_term>Muscular Dystrophies</mesh_term>
	<mesh_term>Polyneuropathies</mesh_term>
	<mesh_term>Radiculopathy</mesh_term>
	<mesh_term>Neuromuscular Diseases</mesh_term>
	<mesh_term>Mononeuropathies</mesh_term>
	<criteria>History of a welldefined, localized or generalized neuromuscular condition producing weakness or muscle atrophy, including disuse atrophy. Multiple generalized neuromuscular conditions.</criteria>
	<gender>All</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>March 2017</verification_date>
</DOC>